THURSDAY, OCTOBER 19, 2017

Loyola University Maryland

4501 N Charles St
Baltimore, MD - 21210

Loyola University Maryland News

Maryland researchers produce experimental malaria vaccine

University of Maryland School of Medicine researchers have conducted a new study and have produced an experimental vaccine that can protect adults from malaria for more than a year. Read More »

Maryland researchers discover potential MERS treatment

Scientists at the University of Maryland School of Medicine recently found a potential new treatment for Middle East Respiratory Syndrome (MERS) that uses genetically modified cows to produce antibodies to fight the infection. Read More »

University of Maryland's Ebola vaccine declared safe and effective

A recent clinical trial shows that a new Ebola vaccine (ChAd3-EBO-Z) provokes a strong immune response and has positive toleration in adults living in Mali and in the U.S. Read More »

Maryland researchers report decoy molecule may decrease flu deaths

A scientist from the University of Maryland School of Medicine recently identified a “decoy” molecule that may be crucial to reducing the risk of flu deaths each year. Read More »

IHV receives grant to fight AIDS in Botswana

The Institute of Human Virology (IHV), a branch of the University of Maryland School of Medicine, recently accepted a $24.5 million grant for the next five years to show how comprehensive treatment programs for HIV/AIDS can fight the epidemic. Read More »

University of Maryland launches institute for vaccine development and malaria treatment

University of Maryland School of Medicine leaders recently announced plans to launch a new Institute for Global Health that will unite decades of research and development for vaccine development and malaria treatment. Read More »